Activating mutations can occur in exons 3, 7, or 8 of the CTNNB1 gene in HCC and HCA [8] and are found in 20–34% of HCCs, suggesting that β-catenin is the most frequently activated oncogene in HCC [9]. The gene discussed is CTNNB1; the disease is hepatocellular adenoma.